Jongkundang Reports 1.6924 Trillion Won in Sales Last Year... Operating Profit Down 19%
"Impact of Expanded R&D and Increased SG&A Expenses"
Jongkundang's consolidated sales increased last year, but operating profit and net profit both saw double-digit declines due to higher research and development expenses and increased selling and administrative costs.
On February 2, Jongkundang announced via a public disclosure that its consolidated sales for 2025 reached 1.6924 trillion won, up 6.7% from the previous year. During the same period, operating profit dropped by 19.0% to 80.6 billion won, while net profit decreased by 30.2% to 77.8 billion won.
The decline in profit was largely attributed to increased research and development expenses. A company representative explained, "Recently, the number of projects entering new phases has increased as we received clinical approvals in the United States and Europe. When clinical trials progress to the next stage, research and development costs temporarily rise due to factors such as trial design and patient recruitment."
Currently, Jongkundang is conducting European clinical trials for its biosimilar pipeline products CKD-704 and CKD-706. The company is also accelerating clinical development for major pipeline candidates such as the ADC-based anticancer drug CKD-703.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The decrease in net profit was also affected by a one-off factor related to a corporate tax refund in the previous year. A company representative stated, "In the previous fiscal year, net profit temporarily increased due to the reflection of a corporate tax refund. This year, as that factor disappeared, the decline in net profit became more pronounced."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.